Consumer Alert: FOSAMAX® May Cause Osteonecrosis ("Jaw Death")
April 12, 2006
FOSAMAX® is a medicine in the bisphosphonates family that is prescribed widely to prevent bone loss or the decrease of bone density. It is commonly used by post-menopausal women. There have been reports that persons taking FOSAMAX® have developed a severe problem in which bone in their jaws dies. This “jaw death” (also referred to jaw necrosis or jaw decay) often appears after minor trauma such as a tooth extraction. According to press reports, the American Association of Endodontists recently released a position paper that cautions that many patients who take FOSAMAX® may be at risk this terrible complication. Other bisphosphonates such as Actonel may also be implicated.
If you or someone you know has taken FOSAMAX® and has suffered jaw injuries, you may wish to contact us. Please call Tara Sutton at 612-349-8500 or e-mail us here: contact us.
The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.